Author:
Detke Holland C,McDonnell David P,Brunner Elizabeth,Zhao Fangyi,Sorsaburu Sebastian,Stefaniak Victoria J,Corya Sara A
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference28 articles.
1. Lauriello J, Lambert T, Andersen SW, Lin DY, Taylor CC, McDonnell D: An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia. J Clin Psychiatry. 2008, 69: 790-799. 10.4088/JCP.v69n0512.
2. Kane JM, Detke HC, Naber D, Sethuraman G, Lin DY, Bergstrom RF, McDonnell DP: Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia. Am J Psychiatry. 2010, 167: 181-189. 10.1176/appi.ajp.2009.07081221.
3. European Medicines Agency: Assessment report for Zypadhera. 2008, [
http://www.emea.europa.eu/humandocs/PDFs/EPAR/Zypadhera/H-890-en6.pdf
]
4. Electronic Medicines Compendium: Summary of product characteristics for ZYPADHERA 210 mg, 300 mg, and 405 mg, powder and solvent for prolonged release suspension for injection. 2009, [
http://emc.medicines.org.uk/medicine/21361/SPC/ZYPADHERA
]
5. McDonnell DP, Detke HC, Kothare P, Johnson J, Stickelmeyer M, Sorsaburu S, Watson SB, Mitchell MI: Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism. BMC Psychiatry. 2010, 10: 45-10.1186/1471-244X-10-45.
Cited by
99 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献